PT839050E - Metodo de melhorar respostas imunes mediadas por celulas - Google Patents

Metodo de melhorar respostas imunes mediadas por celulas

Info

Publication number
PT839050E
PT839050E PT93921698T PT93921698T PT839050E PT 839050 E PT839050 E PT 839050E PT 93921698 T PT93921698 T PT 93921698T PT 93921698 T PT93921698 T PT 93921698T PT 839050 E PT839050 E PT 839050E
Authority
PT
Portugal
Prior art keywords
cells
immune responses
improving immune
immunogen
vaccinating
Prior art date
Application number
PT93921698T
Other languages
English (en)
Portuguese (pt)
Inventor
Baldir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT839050E publication Critical patent/PT839050E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT93921698T 1992-09-28 1993-09-21 Metodo de melhorar respostas imunes mediadas por celulas PT839050E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
PT839050E true PT839050E (pt) 2004-11-30

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93921698T PT839050E (pt) 1992-09-28 1993-09-21 Metodo de melhorar respostas imunes mediadas por celulas

Country Status (11)

Country Link
EP (1) EP0839050B1 (Sortimente)
JP (1) JPH08502253A (Sortimente)
AT (1) ATE273022T1 (Sortimente)
AU (1) AU687750B2 (Sortimente)
CA (1) CA2145760A1 (Sortimente)
DE (1) DE69333588T2 (Sortimente)
DK (1) DK0839050T3 (Sortimente)
ES (1) ES2225825T3 (Sortimente)
MX (1) MX9306016A (Sortimente)
PT (1) PT839050E (Sortimente)
WO (1) WO1994007531A1 (Sortimente)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1246597B1 (en) 1999-08-03 2015-01-14 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
PT1474067E (pt) * 2001-07-02 2008-11-14 Pfizer Prod Inc Vacinação numa dose com mycoplasma hyopneumoniae
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
AU2006261342B2 (en) 2005-06-15 2012-02-02 The Ohio State University Research Foundation Her-2 peptides
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
WO2011141443A1 (en) 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
JP3187419B2 (ja) * 1990-05-29 2001-07-11 アメリカン・サイアナミド・カンパニー ブタ肺炎ワクチンおよびその製造方法
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
ES2225825T3 (es) 2005-03-16
EP0839050B1 (en) 2004-08-11
AU4931293A (en) 1994-04-26
AU687750B2 (en) 1998-03-05
EP0839050A1 (en) 1998-05-06
WO1994007531A1 (en) 1994-04-14
MX9306016A (es) 1995-01-31
ATE273022T1 (de) 2004-08-15
JPH08502253A (ja) 1996-03-12
EP0839050A4 (Sortimente) 1998-05-06
DE69333588D1 (de) 2004-09-16
DK0839050T3 (da) 2004-10-25
CA2145760A1 (en) 1994-04-14
DE69333588T2 (de) 2005-08-04

Similar Documents

Publication Publication Date Title
ZA91559B (en) Vaccines against cancer and infectious diseases
ES2059369T3 (es) Formulacion de vacuna.
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
DK0714444T3 (da) Dæmpning af en immundominant epitop i et antigen til anvendelse i plante-, dyre- og humanvacciner og immunbehandlinger
ES2152421T3 (es) Vacunas de conjugados polisacarido neumococcico-neumolisina recombinante para la inmunizacion contra las infecciones neumococcicas.
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
DE3486293D1 (de) Impfstoff-Zubereitung.
PT839050E (pt) Metodo de melhorar respostas imunes mediadas por celulas
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
DE2967036D1 (en) Vaccine and method of making
ES8207429A1 (es) Un procedimiento para la preparacion de un polisacarido antigenico.
JPS5726623A (en) Vaccine and manufacture
DK16087D0 (da) Mastitis-vaccine
DE68917138D1 (de) Toleranzinduktion gegenüber einem fremdantigen.
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
NZ212274A (en) Method of producing anti-male antibodies, antibodies so produced and lymphocytes
Ervucharakul et al. Experience in hepatitis B vaccination in general population.
CHEN et al. INVESTIGATION ON PRINCIPLE PARASITIC INFECTIONS IN THE SOUTHERN PART OF JIANGSU PROVINCE
YU et al. Comparision of immunogenicity of vaccine produced by different rabies the strain
Zheng et al. Studies on the biological properties of a chemical vaccine prepared from antigenic fractions of Vibrio cholerae.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen